Keywords: novartis, buys, generics, cancer, firm, 2b, says

Novartis buys generics cancer firm for $1.2B

Article | 20 May 2009

Print This

Novartis says it is planning to acquire the Austrian firm EBEWE Pharma to create a strategic generic oncology injectable business ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in